Viewing nowTebafine Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 200400802 · Notified 2004.09.14 · Insurance code 640901180
Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis
This medication is used to treat tinea pedis, tinea corporis, and tinea cruris caused by dermatophytes in adults. It is also effective for fungal infections affecting the nails. In children, it can help treat tinea capitis. In conclusion, this drug is used to treat various skin and nail fungal infections.
1. Adults Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris (jock itch): 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. In cases of infection of a fingernail or a relatively small toenail, or in younger patients, the treatment duration may be shortened to 3 months or less. Treatment of toenail infections usually requires 3 months, but some patients may require 6 months or longer. The treatment duration may be longer in patients with slow nail growth. 3. Patients with renal impairment For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
2. Pediatric patients: Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be given regularly and for the prescribed duration. 1) Body weight less than 20 kg (under 5 years of age): 62.5 mg per dose, once daily. As experience with use is limited, the decision to administer should be made after considering the benefits and risks of treatment. 2) Body weight 20~40 kg (5 to 12 years of age): 125 mg per dose, once daily. 3) Body weight over 40 kg (over 12 years of age): 250 mg per dose, once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Regular liver function tests should be conducted before and during treatment to check for liver function issues. If liver function deteriorates or symptoms of liver dysfunction (persistent nausea, loss of appetite, fatigue, vomiting, upper right abdominal pain, jaundice, etc.) appear, it is crucial to inform a doctor immediately and discontinue use. Although this medication is used to treat onychomycosis, serious liver failure can occur rarely, so liver health should be monitored carefully. Those allergic to this medication, individuals with chronic liver disease, blood disorders, severe renal failure, infants under 2 years of age, nursing mothers, and those with hereditary lactose intolerance should not take it. Patients with impaired kidney function, elderly patients, and children weighing less than 20 kg should use this medication with caution, and if severe skin reactions occur, they should stop taking it immediately. Common side effects may include skin rash or itching, joint pain, muscle aches, dyspepsia, headaches, taste disorders, and depression, and if symptoms are severe, consultation with a doctor is advisable. This medication may cause dizziness when driving or operating machinery, so caution is required. There may also be interactions with other medications, so it is essential to inform a doctor or pharmacist about any other medications being taken, especially when used with drugs metabolized by the liver. Pregnant women or women who may become pregnant should consult with a doctor and carefully decide on the use of this drug, and breastfeeding should be discontinued if applying this medication. In cases of overdose, symptoms such as headaches, nausea, abdominal pain, and dizziness may occur, and immediate medical treatment should be sought. This medication should be kept out of reach of children and stored at room temperature away from direct sunlight.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, γ-GTP elevation, AST/ALT elevation, LDH elevation, ALP elevation, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous bleeding, leukopenia, anemia, rash, itching, photosensitivity reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesiculobullous dermatitis, psoriasiform rash, psoriasis exacerbation, hair loss, musculoskeletal reaction, arthralgia, myalgia, weakness, CPK elevation, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangitis, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, abnormal sensation, decreased sensation, decreased attention, insomnia, BUN elevation, increased urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, increased total cholesterol, increased triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is recommended to keep it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.